In the Hemochromatosis and Iron Overload Screening Study of adult primary care participants in North America, 8.5% of 176 HFE C282Y homozygotes and 10.9% of 312 HFE  wt/wt controls reported taking thyroid supplements (p = 0.4019) [52]. This evidence concerns the gene HFE and hemochromatosis.